EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunotherapy in Ocular Fungal Infections: Advances and Emerging Strategies

Agimanailiu Khapuinamai, Joveeta Joseph

Current Microbiology · 2026-06 · 83 (6)

DOI: 10.1007/s00284-026-04893-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Microbiology, online erschienen am 03.05.2026. Verfasst von Agimanailiu Khapuinamai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jhaveri Microbiology Centre, Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, Telangana, 500034, India. Hauptthemen laut MEDLINE: Immunotherapy, Eye Infections, Fungal. Die Arbeit nennt 138 Literaturangaben. Gefördert von: Indian Council of Medical Research, Lady Tata Memorial Trust, Hyderabad Eye Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular fungal infections, represent a significant global health burden, particularly in tropical and subtropical regions. Conventional antifungal therapies often suffer from poor ocular bioavailability, delayed diagnosis, toxicity, and limited efficacy, especially in immunocompromised individuals. Given the critical role of host immunity in determining disease outcomes, immunomodulation has emerged as a promising adjunctive strategy to enhance antifungal defense while mitigating immunopathology. This review highlights the complex interplay between innate and adaptive immune responses in ocular fungal infections and explores emerging immunotherapeutic approaches such as host defense peptides, cytokine therapies (e.g., IFN-γ, IL-6, IL-17, IL-33), cellular therapies (e.g., MSCs, CAR-T cells, dendritic cells), and extracellular vesicle-based interventions. Despite existing challenges including the complexity of ocular immunopathology and the logistical hurdles of clinical trials Immunomodulatory therapies have the potential to shift the current treatment paradigm for ocular fungal infections, advancing from traditional pathogen-targeted approaches to more precise, host-directed interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyEye Infections, FungalHumansHost-Directed TherapyAnimalsImmunity, InnateCytokinesAntifungal AgentsAdaptive Immunity

Substanzen

CytokinesAntifungal Agents

Autor:innen und Institutionen

  • Jhaveri Microbiology Centre, Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, Telangana, 500034, India.
  • Center for Doctoral Studies, Manipal Academy of Higher Education, Karnataka, 576104, Manipal, India.
  • Jhaveri Microbiology Centre, Brien Holden Eye Research Centre, LV Prasad Eye Institute, Hyderabad, Telangana, 500034, India. joveeta@lvpei.org.

Förderung

  • Indian Council of Medical Research
  • Lady Tata Memorial Trust
  • Hyderabad Eye Research Foundation

Zitieren

APA

Khapuinamai, A., & Joseph, J. (2026). Immunotherapy in Ocular Fungal Infections: Advances and Emerging Strategies. Current Microbiology, 83(6). https://doi.org/10.1007/s00284-026-04893-3

Vancouver

Khapuinamai A, Joseph J. Immunotherapy in Ocular Fungal Infections: Advances and Emerging Strategies. Current Microbiology. 2026;83(6). doi:10.1007/s00284-026-04893-3

BibTeX
@article{Khapuinamai2026,
  author = {Khapuinamai, Agimanailiu and Joseph, Joveeta},
  title = {Immunotherapy in Ocular Fungal Infections: Advances and Emerging Strategies},
  journal = {Current Microbiology},
  year = {2026},
  volume = {83},
  number = {6},
  doi = {10.1007/s00284-026-04893-3}
}
Kostenlos starten →